This Form of Rare Interstitial Lung Disease is Bad News for Scleroderma Patients
kalhh / Pixabay

This Form of Rare Interstitial Lung Disease is Bad News for Scleroderma Patients

According to a story from Scleroderma News, a recent study has recommended that scleroderma patients with a rare, poorly understood form of interstitial lung disease (ILD) should receive regular monitoring…

Continue Reading This Form of Rare Interstitial Lung Disease is Bad News for Scleroderma Patients
Despite New Rules, Extreme Costs Make Hospitals Balk at Offering the Latest and Greatest Therapies
DarkoStojanovic / Pixabay

Despite New Rules, Extreme Costs Make Hospitals Balk at Offering the Latest and Greatest Therapies

According to a story from statnews.com, new, groundbreaking forms of treatment, such as gene therapy and CAR-T cell therapy, are giving patients with rare genetic disorders and advanced cancers more…

Continue Reading Despite New Rules, Extreme Costs Make Hospitals Balk at Offering the Latest and Greatest Therapies
Primary Immunodeficiency in Children: Early Intervention is Important
RachelBostwick / Pixabay

Primary Immunodeficiency in Children: Early Intervention is Important

According to a story from The Indian Express, early treatment and diagnosis of primary immunodeficiencies makes management of this group of disease much simpler as a whole. In children, the…

Continue Reading Primary Immunodeficiency in Children: Early Intervention is Important
This Idiopathic Pulmonary Fibrosis Clinic is Improving Patient Quality of Life
truthseeker08 / Pixabay

This Idiopathic Pulmonary Fibrosis Clinic is Improving Patient Quality of Life

According to a story from Medical Xpress, the Alberta Health Services' Kaye Edmonton Interstitial Lung Disease Clinic is taking a more patient-centered approach to palliative care for patients with idiopathic…

Continue Reading This Idiopathic Pulmonary Fibrosis Clinic is Improving Patient Quality of Life
IWMF and PleXus Communications are Teaming up to Help Spread Waldenstrom’s Macroglobulinemia Awareness
Nappiness / Pixabay

IWMF and PleXus Communications are Teaming up to Help Spread Waldenstrom’s Macroglobulinemia Awareness

The International Waldenstrom's Macroglobulinemia Foundation (IWMF) has recently announced an exciting new partnership that will help facilitate spreading awareness about Waldenstrom's macroglobulinemia (WM), a rare form of blood cancer. This…

Continue Reading IWMF and PleXus Communications are Teaming up to Help Spread Waldenstrom’s Macroglobulinemia Awareness

An Experimental Treatment for POMC and LEPR Deficiency Obesity Appears Effective

According to a story from sectorpublishingintelligence.co.uk, the biopharmaceutical company Rhythm Pharmaceuticals, Inc., has recently announced the results from two phase 3 clinical trials. These trials were testing the company's experimental…

Continue Reading An Experimental Treatment for POMC and LEPR Deficiency Obesity Appears Effective

A Potential Treatment for Familial Chylomicronemia Syndrome Performs Well in Trials

According to a story from EurekAlert!, the results of a recent clinical trial should get the attention of patients in the US with the rare disorder familial chylomicronemia syndrome. The…

Continue Reading A Potential Treatment for Familial Chylomicronemia Syndrome Performs Well in Trials
Large Scale Trial Aims to Test Precision Medicines Based on Genomic Profiling in a Variety of Cancers
source: pixabay.com

Large Scale Trial Aims to Test Precision Medicines Based on Genomic Profiling in a Variety of Cancers

According to a story from Newswise, Quest Diagnostics, a laboratory that specializes in diagnostic information, has announced plans to participate in a unique, large scale trial called NCI-MATCH, which stands…

Continue Reading Large Scale Trial Aims to Test Precision Medicines Based on Genomic Profiling in a Variety of Cancers
The Drug Abatacept Appears Beneficial in Systemic Sclerosis Despite Missing Primary Endpoint
mwooten / Pixabay

The Drug Abatacept Appears Beneficial in Systemic Sclerosis Despite Missing Primary Endpoint

According to a story from Medpage Today, a recent study testing the medication abatacept (marketed as Orencia) as a treatment for diffuse cutaneous systemic sclerosis concluded with rather mixed results.…

Continue Reading The Drug Abatacept Appears Beneficial in Systemic Sclerosis Despite Missing Primary Endpoint

Company Cleared to Begin Trials for Experimental Retinitis Pigmentosa Drug

According to a story from globenewswire.com, the drug developer ProQR Therapeutics N.V. has recently announced that the US Food and Drug Administration (FDA) has officially cleared the company's Investigational New…

Continue Reading Company Cleared to Begin Trials for Experimental Retinitis Pigmentosa Drug
First Patient Enrolls for Primary Sclerosing Cholangitis Proof-of-Concept Study
DarkoStojanovic / Pixabay

First Patient Enrolls for Primary Sclerosing Cholangitis Proof-of-Concept Study

According to a story from BioSpace, the biopharmaceutical company Immunic, Inc. has announced that the first patient has signed up for its proof-of-concept clinical study. This study is intended to…

Continue Reading First Patient Enrolls for Primary Sclerosing Cholangitis Proof-of-Concept Study